Technical Analysis for SIOX - Sio Gene Therapies Inc
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | N/A | N/A | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
MACD Bullish Signal Line Cross | Bullish | 0.00% | |
Stochastic Buy Signal | Bullish | 0.00% | |
Gapped Up | Strength | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
20 DMA Resistance | Bearish | 1.07% | |
Inside Day | Range Contraction | 1.07% | |
Oversold Stochastic | Weakness | 1.07% | |
20 DMA Resistance | Bearish | 1.07% | |
Shooting Star Candlestick | Bearish | 1.07% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
20 DMA Support | 2 days ago |
10 DMA Support | 2 days ago |
Rose Above 20 DMA | 2 days ago |
Rose Above 10 DMA | 2 days ago |
Reversed from Up | 2 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.
Keywords: Emerging Technologies Life Sciences Biology Gene Therapy Neurodegenerative Diseases Medical Genetics Molecular Biology Genetic Engineering Gene Delivery Gene Therapy Product Roivant Sciences
Classification
Keywords: Emerging Technologies Life Sciences Biology Gene Therapy Neurodegenerative Diseases Medical Genetics Molecular Biology Genetic Engineering Gene Delivery Gene Therapy Product Roivant Sciences
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 0.429 |
52 Week Low | 0.3911 |
Average Volume | 86,192 |
200-Day Moving Average | 0.0000 |
50-Day Moving Average | 0.0000 |
20-Day Moving Average | 0.4041 |
10-Day Moving Average | 0.4029 |
Average True Range | 0.0083 |
RSI (14) | 50.50 |
ADX | 17.82 |
+DI | 12.7350 |
-DI | 7.1795 |
Chandelier Exit (Long, 3 ATRs) | 0.3948 |
Chandelier Exit (Short, 3 ATRs) | 0.4249 |
Upper Bollinger Bands | 0.4123 |
Lower Bollinger Band | 0.3959 |
Percent B (%b) | 0.59 |
BandWidth | 4.0584 |
MACD Line | -0.0014 |
MACD Signal Line | -0.0015 |
MACD Histogram | 0.0001 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.4144 | ||||
Resistance 3 (R3) | 0.4139 | 0.4104 | 0.4129 | ||
Resistance 2 (R2) | 0.4104 | 0.4082 | 0.4107 | 0.4124 | |
Resistance 1 (R1) | 0.4080 | 0.4068 | 0.4063 | 0.4085 | 0.4119 |
Pivot Point | 0.4045 | 0.4045 | 0.4037 | 0.4048 | 0.4045 |
Support 1 (S1) | 0.4021 | 0.4023 | 0.4004 | 0.4026 | 0.3991 |
Support 2 (S2) | 0.3986 | 0.4009 | 0.3989 | 0.3986 | |
Support 3 (S3) | 0.3962 | 0.3986 | 0.3981 | ||
Support 4 (S4) | 0.3967 |